Ilir Qirko

• Resourceful biopharma professional with broad understanding of the P&MA landscape in the USA and EU5 • Experience in developing multi-indication and label expansion strategies to maximize commercial opportunity • Proven ability to identify and develop Payer Value Propositions in Specialty / Oncology therapeutic space • Proficiency in analogue assessments for pipeline assets to extract key P&MA learnings for actionable recommendations • Ability to succinctly communicate complex findings at multiple levels of a biopharmaceutical organization